Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Differentiated Thyroid Cancer”

242 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 242 results

Not applicableUnknownNCT04563780
What this trial is testing

The Prognostic Value of Post Thyroidectomy 99mTCpertechnetate Thyroid Scan in Patient With Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer
Assiut University 113
Testing effectiveness (Phase 2)Study completedNCT00654238
What this trial is testing

Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer

Who this might be right for
Metastatic Differentiated Thyroid CancerMetastatic Poorly Differentiated Thyroid CancerMetastatic Anaplastic Thyroid Cancer+1 more
University of Pennsylvania 59
Not applicableUnknownNCT04858867
What this trial is testing

Reinducing Radioiodine-sensitivity in Radioiodine-refractory DTC Using Lenvatinib (RESET)

Who this might be right for
Differentiated Thyroid Cancer
Leiden University Medical Center 12
Not applicableNot Yet RecruitingNCT06845098
What this trial is testing

Impact of Thyroid Treatment on Ovarian Function and Pregnancy Outcomes in Women with Differentiated Thyroid Cancer

Who this might be right for
Thyroid Gland
Zhejiang Provincial People's Hospital 300
Not applicableEnded earlyNCT05014698
What this trial is testing

IDEntification of New Predisposition Genes in Differentiated THYroid Cancer

Who this might be right for
Differentiated Thyroid CancerThyroid Cancer, Nonmedullary
Nantes University Hospital 34
Testing effectiveness (Phase 2)Looking for participantsNCT06235216
What this trial is testing

Sacituzumab govitEcan in THYroid Cancers

Who this might be right for
Differentiated Thyroid CancerAnaplastic Thyroid Cancer
Grupo Espanol de Tumores Neuroendocrinos 42
Not applicableUnknownNCT01700699
What this trial is testing

Impact of BRAFV600E Intratumor Heterogeneity in Thyroid Cancer Treated With Tyrosine Kinase Inhibitors

Who this might be right for
Differentiated Thyroid Cancer
University of Salerno 50
Not applicableStudy completedNCT00454077
What this trial is testing

RhTSH-Thyroid Ablation With 1850 MBq of 131I

Who this might be right for
Thyroid Cancer
University of Siena 72
Not applicableLooking for participantsNCT07545837
What this trial is testing

Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors

Who this might be right for
Thyroid Gland Follicular CarcinomaThyroid Gland Papillary Carcinoma
Mayo Clinic 20
Testing effectiveness (Phase 2)Study completedNCT00381641
What this trial is testing

Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery

Who this might be right for
Differentiated Thyroid Gland CarcinomaRecurrent Thyroid Gland CarcinomaRefractory Thyroid Gland Carcinoma+16 more
National Cancer Institute (NCI) 63
Testing effectiveness (Phase 2)Study completedNCT02702388
What this trial is testing

A Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile

Who this might be right for
Thyroid Cancer
Eisai Inc. 241
Testing effectiveness (Phase 2)Ended earlyNCT03002623
What this trial is testing

CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer

Who this might be right for
Thyroid NeoplasmsPoorly Differentiated and Undifferentiated Thyroid CancerDifferentiated Thyroid Cancer
National Cancer Institute (NCI) 7
Testing effectiveness (Phase 2)Study completedNCT01270321
What this trial is testing

Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer

Who this might be right for
Thyroid Cancer
Emory University 42
Large-scale testing (Phase 3)UnknownNCT00415233
What this trial is testing

High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer

Who this might be right for
Head and Neck Cancer
University College, London 438
Testing effectiveness (Phase 2)UnknownNCT03387943
What this trial is testing

PLD Combined With Cisplatin in the Treatment of Advanced Poorly Differentiated Thyroid Carcinoma

Who this might be right for
Poorly Differentiated Thyroid Carcinoma
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 30
Not applicableStudy completedNCT03176485
What this trial is testing

Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors

Who this might be right for
Metastatic CancerMelanomaColon Cancer+6 more
University of Arizona 45
Testing effectiveness (Phase 2)UnknownNCT04554680
What this trial is testing

Clinical Trial in RAI-Refractory Thyroid Carcinoma Evaluating BRAF & MEK Blockade for Re-differentiation Therapy

Who this might be right for
Thyroid Cancer
National University Hospital, Singapore 5
Not applicableStudy completedNCT07229859
What this trial is testing

Robotic Surgery Via Bilateral Axillo-breast Approach for Relatively Low-risk Papillary Thyroid Carcinoma With Lateral Cervical Lymph Node Metastasis: a Safe and Effective Cosmetic Procedure in the Context of Prevalent Thyroid Ultrasound Screening

Who this might be right for
Differentiated Thyroid Cancer (DTC)Robotic Assistance
Ruijin Hospital 332
Post-approval studies (Phase 4)UnknownNCT05466812
What this trial is testing

Efficacy of Sr-89 for Differentiated Thyroid Cancer With Bone Metastases

Who this might be right for
Thyroid Neoplasm FollicularBone Metastases
Peking Union Medical College Hospital 20
Not applicableActive Not RecruitingNCT06422702
What this trial is testing

The Effect of a Psychosomatic Symptom Intervention Program on the Primary Treatment of Differentiated Thyroid Cancer

Who this might be right for
Pathologically Confirmed Differentiated Thyroid CarcinomaAll Patients Are in the Initial Treatment PhaseNormal Cognitive and Communicative Abilities, Capable of Reading and Understanding Questionnaires in Chinese+2 more
Harbin Medical University
Next Page
84